Severe acute respiratory syndrome
Citation, DOI & article data
The severe acute respiratory syndrome (SARS) is a zoonotic illness caused by severe acute respiratory syndrome-related coronavirus (SARS-CoV-1), a coronavirus. The disease was first seen in the city of Foshan in Guangdong Province in China in 2002 and was traced back to the Himalayan (masked) palm civet, racoon dogs and the Chinese ferret-badger. All of these animals are sold in the live wild animal markets in China 1. The civet cats were thought to be the intermediaries who passed the SARS virus from bats to humans.
Following the discovery of SARS-CoV-2, the Arabic numeric digit 1 was suffixed to the name of the SARS-related coronavirus, creating the retronymic SARS-CoV-1 7.
From 2002-2003 there were over 8,000 confirmed cases of SARS (21% of which were in health care workers), leading to 813 deaths 1. Outside of Asia, Canada was the most affected nation, with the majority of cases secondary to exposure within a healthcare facility. The severe acute respiratory syndrome crisis in Canada lead to a major revision of infection control practice, surge capacity planning, and the formation of the Canadian public health agency 4.
Currently there are no active reported cases of SARS-CoV-1 infection worldwide.
Patients with SARS present with flu-like symptoms that will either show clinical improvement after the first week (30% of patients) or require intensive care treatment (20-30% of patients). A history of SARS-CoV-1 contact is often found. Initial symptoms include 1-3:
- acute respiratory distress syndrome (ARDS)
- acute cardiac injury
- acute renal failure
- encephalitis 6
The SARS-related coronavirus-1 (SARS-CoV-1) is a member of the Betacoronavirus genus, one of the genera of the Coronaviridae family of viruses. Coronaviruses are enveloped single-stranded RNA viruses, that are found in humans, many other mammals and birds. These viruses are responsible for pulmonary, hepatic, CNS and intestinal disease.
Hitherto, seven coronaviruses have been found to be responsible for human diseases, two more are zoonoses, COVID-19 and Middle East respiratory syndrome coronavirus (MERS-CoV), both of which may sometimes be fatal. The remaining four viruses are ubiquitous in human societies worldwide and cause mild coryzal illnesses.
- focal opacity (most common)
- multifocal opacity often contrasted to the middle and lower zones
- ground-glass opacities (unilateral or bilateral)
Treatment and prognosis
No specific treatment exists for severe acute respiratory syndrome. Patients are given broad-spectrum antibiotics as well as antivirals, steroids, and supportive therapy 3. Vaccines for SARS-CoV-2 are widely available.
- 1. Cleri D, Ricketti A, Vernaleo J. Severe Acute Respiratory Syndrome (SARS). Infect Dis Clin North Am. 2010;24(1):175-202. doi:10.1016/j.idc.2009.10.005
- 2. Gu J & Korteweg C. Pathology and Pathogenesis of Severe Acute Respiratory Syndrome. Am J Pathol. 2007;170(4):1136-47. doi:10.2353/ajpath.2007.061088
- 3. Paul N, Roberts H, Butany J et al. Radiologic Pattern of Disease in Patients with Severe Acute Respiratory Syndrome: The Toronto Experience. Radiographics. 2004;24(2):553-63. doi:10.1148/rg.242035193
- 4. Johnston B & Conly J. Severe Acute Respiratory Syndrome: What Have We Learned Two Years Later? Canadian Journal of Infectious Diseases and Medical Microbiology. 2004;15(6):309-12. doi:10.1155/2004/964258
- 5. Ng LFP, Hiscox JA. Coronaviruses in animals and humans. (2020) BMJ (Clinical research ed.). 368: m634. doi:10.1136/bmj.m634 - Pubmed
- 6. Wu Y, Xu X, Chen Z et al. Nervous System Involvement After Infection with COVID-19 and Other Coronaviruses. Brain Behav Immun. 2020;87:18-22. doi:10.1016/j.bbi.2020.03.031
- 7. Cordes A & Heim A. Rapid Random Access Detection of the Novel SARS-Coronavirus-2 (SARS-CoV-2, Previously 2019-NCoV) Using an Open Access Protocol for the Panther Fusion. J Clin Virol. 2020;125:104305. doi:10.1016/j.jcv.2020.104305